| 1 |
Kip E, Parr-Brownlie LC. Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease. Ageing Res Rev 2022;78:101618. [PMID: 35395416 DOI: 10.1016/j.arr.2022.101618] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 2 |
Kimono DA. Gastrointestinal problems, mechanisms and possible therapeutic directions in Gulf war illness: a mini review. Mil Med Res 2021;8:50. [PMID: 34503577 DOI: 10.1186/s40779-021-00341-4] [Reference Citation Analysis]
|
| 3 |
Yue Q, Cai M, Xiao B, Zhan Q, Zeng C. The Microbiota-Gut-Brain Axis and Epilepsy. Cell Mol Neurobiol 2021. [PMID: 34279746 DOI: 10.1007/s10571-021-01130-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 4 |
Tunç U, Yıldırım Y, Çelebi ARC, Kepez Yıldız B. Potential role of ocular surface microbiota in keratoconus etiopathogenesis. Expert Review of Ophthalmology 2021;16:333-41. [DOI: 10.1080/17469899.2021.1942844] [Reference Citation Analysis]
|
| 5 |
Mohamed SS, Abdeltawab NF, Wadie W, Ahmed LA, Ammar RM, Rabini S, Abdel-Aziz H, Khayyal MT. Effect of the standard herbal preparation, STW5, treatment on dysbiosis induced by dextran sodium sulfate in experimental colitis. BMC Complement Med Ther 2021;21:168. [PMID: 34103031 DOI: 10.1186/s12906-021-03337-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Wang Y, Tao H, Huang H, Xiao Y, Wu X, Li M, Shen J, Xiao Z, Zhao Y, Du F, Ji H, Chen Y, Cho CH, Wang Y, Wang S, Wu X. The dietary supplement Rhodiola crenulata extract alleviates dextran sulfate sodium-induced colitis in mice through anti-inflammation, mediating gut barrier integrity and reshaping the gut microbiome. Food Funct 2021;12:3142-58. [PMID: 33729231 DOI: 10.1039/d0fo03061a] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 7 |
Dang X, Xu M, Liu D, Zhou D, Yang W. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis. PLoS One. 2020;15:e0228846. [PMID: 32182248 DOI: 10.1371/journal.pone.0228846] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 8 |
Huang H, Xu H, Luo Q, He J, Li M, Chen H, Tang W, Nie Y, Zhou Y. Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report. Medicine (Baltimore) 2019;98:e16163. [PMID: 31261545 DOI: 10.1097/MD.0000000000016163] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 18.8] [Reference Citation Analysis]
|
| 9 |
Sitkin SI, Vakhitov TY, Demyanova EV. Microbiome, gut dysbiosis and inflammatory bowel disease: That moment when the function is more important than taxonomy. Alʹm klin med 2018;46:396-425. [DOI: 10.18786/2072-0505-2018-46-5-396-425] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 10 |
Camara-Lemarroy CR, Metz LM, Yong VW. Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome. World J Gastroenterol 2018; 24(37): 4217-4223 [PMID: 30310254 DOI: 10.3748/wjg.v24.i37.4217] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 11 |
Guo HX, Ye N, Yan P, Qiu MY, Zhang J, Shen ZG, He HY, Tian ZQ, Li HL, Li JT. Sodium chloride exacerbates dextran sulfate sodium-induced colitis by tuning proinflammatory and antiinflammatory lamina propria mononuclear cells through p38/MAPK pathway in mice. World J Gastroenterol 2018; 24(16): 1779-1794 [PMID: 29713131 DOI: 10.3748/wjg.v24.i16.1779] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 12 |
Enck P, Mazurak N. Dysbiosis in Functional Bowel Disorders. Ann Nutr Metab. 2018;72:296-306. [PMID: 29694952 DOI: 10.1159/000488773] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 13 |
Schneider A, Maric L. Fecal Microbiota Transplantation as Therapy for Inflammatory Bowel Disease. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications 2018. [DOI: 10.1016/b978-0-12-811388-2.00028-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 14 |
Young W, Jester T, Stoll ML, Izcue A. Inflammatory Bowel Disease. The Microbiome in Rheumatic Diseases and Infection 2018. [DOI: 10.1007/978-3-319-79026-8_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 15 |
Basson AR, Lam M, Cominelli F. Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches. Gastroenterol Clin North Am 2017;46:689-729. [PMID: 29173517 DOI: 10.1016/j.gtc.2017.08.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 16 |
Thaiss CA, Elinav E. The remedy within: will the microbiome fulfill its therapeutic promise? J Mol Med (Berl) 2017;95:1021-7. [PMID: 28656322 DOI: 10.1007/s00109-017-1563-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 17 |
He Z, Cui BT, Zhang T, Li P, Long CY, Ji GZ, Zhang FM. Fecal microbiota transplantation cured epilepsy in a case with Crohn’s disease: The first report. World J Gastroenterol 2017; 23(19): 3565-3568 [PMID: 28596693 DOI: 10.3748/wjg.v23.i19.3565] [Cited by in CrossRef: 129] [Cited by in F6Publishing: 132] [Article Influence: 21.5] [Reference Citation Analysis]
|
